Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Marinus Pharma CS (NQ: MRNS )

14.16 USD +0.17 (+1.22%)
Official Closing Price Updated: 7:47 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 170,400
Open 14.00
Bid (Size) 13.35 (1)
Ask (Size) 14.20 (1)
Prev. Close 13.99
Today's Range 13.85 - 14.29
52wk Range 6.040 - 20.04
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Marinus Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MARINUS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) 
From Business Wire News Releases
Marinus Pharmaceuticals Bolsters Leadership Team with Two New Appointments
Marinus Pharmaceuticals announced Steven E. Pfanstiel as Chief Financial Officer and Lisa Lejuwaan as Vice President of Sales. 
From Business Wire News Releases

Performance

YTD
+16.07%
+16.07%
1 Month
-10.04%
-10.04%
3 Month
+16.64%
+16.64%
6 Month
-6.29%
-6.29%
1 Year
+91.35%
+91.35%

More News

Read More
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur to Board of Directors
From Business Wire News Releases
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results
From Business Wire News Releases
Marinus Pharmaceuticals Unveils New Brand as the Company Prepares for Commercialization
From Business Wire News Releases
Analysts See 35% Gains Ahead For PILL
Tags ETFs
From ETF Channel
Marinus Pharmaceuticals to Participate in Multiple Investor Healthcare and Life Sciences Conferences
From Business Wire News Releases
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Marinus Pharmaceuticals to Provide Business Update and Announce Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's Intraday Session
Tags Movers IBRX SEEL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.